Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL5191853

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@H](O)CNCCCc1ccc(Cl)cc1

Basic Information

ChEMBL ID CHEMBL5191853
Phase Preclinical
Structure Type MOL
InChI Key HOHJUNBKAOXZGI-SCDRESIJSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names

Molecular Properties

464.1
MW (Da)
4.02
ALogP
4
HBA
3
HBD
64.6
PSA (Ų)
0.48
QED
0
Ro5 Violations
9
Rot. Bonds

Drug Information

Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C26H42ClN3O2
MW 464.09
Aromatic Rings 1
Heavy Atoms 32
NP-Likeness -0.41

Activity Summary

IC50 1 meas. best 5.96

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
IC50 5.96 5.96 1110.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked IC50 = 1110.0 nM 5.96 Inhibition of glycoprotein in luciferase expressing pseudotyped Ebola virus infe... 35872393

Literature References

PubMed DOI Target Context # Activities
35872393 10.1016/j.ejmech.2022.114608 Unchecked 2
35872393 10.1016/j.ejmech.2022.114608 Huh-7 1
35872393 10.1016/j.ejmech.2022.114608 ADMET 1

Data from ChEMBL 36 via Core Engine